N-[2-(4-hydroxyphenyl)ethyl]hexanamide

Modify Date: 2024-09-23 10:08:24

N-[2-(4-hydroxyphenyl)ethyl]hexanamide Structure
N-[2-(4-hydroxyphenyl)ethyl]hexanamide structure
Common Name N-[2-(4-hydroxyphenyl)ethyl]hexanamide
CAS Number 1184818-23-2 Molecular Weight 235.322
Density 1.0±0.1 g/cm3 Boiling Point 452.6±28.0 °C at 760 mmHg
Molecular Formula C14H21NO2 Melting Point N/A
MSDS N/A Flash Point 227.5±24.0 °C

 Names

Name N-CAPROYL TYRAMINE
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.0±0.1 g/cm3
Boiling Point 452.6±28.0 °C at 760 mmHg
Molecular Formula C14H21NO2
Molecular Weight 235.322
Flash Point 227.5±24.0 °C
Exact Mass 235.157227
LogP 2.51
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.525

 Synonyms

MFCD12907228
Hexanamide, N-[2-(4-hydroxyphenyl)ethyl]-
N-CAPROYL TYRAMINE
Top Suppliers:I want be here


Get all suppliers and price by the below link:

N-[2-(4-hydroxyphenyl)ethyl]hexanamide suppliers

N-[2-(4-hydroxyphenyl)ethyl]hexanamide price

Related Compounds: More...
N-[2-(4-hydroxyphenyl)ethyl]formamide
13062-78-7
N-[2-(4-hydroxyphenyl)ethyl]pyridine-3-carboxamide
55458-76-9
N-[2-(4-hydroxyphenyl)ethyl]-4-methylpentanamide
921607-22-9
N-[2-(4-hydroxyphenyl)ethyl]docosanamide
155408-10-9
N-[2-(4-hydroxyphenyl)ethyl]-4-methylbenzenesulfonamide
259263-97-3
N-[2-(4-Hydroxyphenyl)ethyl]methanesulfonamide
883107-35-5
N-[2-(4-hydroxyphenyl)ethyl]propanamide
60394-18-5
N-[2-(4-hydroxyphenyl)ethyl]-2-phenylacetamide
176039-99-9
N-[2-(4-hydroxyphenyl)ethyl]-2-methylpropanamide
921607-19-4
I(2)-D-Glucopyranosiduronic acid, (3I(2),4I+/-,15I+/-,16I+/-,21I(2),22I+/-)-15,16,28-trihydroxy-23-methoxy-21-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-22-(2-methyl-1-oxobutoxy)-23-oxoolean-12-en-3-yl 3-O-I+/--L-arabinopyranosyl-, methyl ester
288153-02-6
I(2)-D-Glucopyranosiduronic acid, (3I(2),16I+/-,18I+/-)-13,28-epoxy-16-hydroxyoleanan-3-yl O-6-deoxy-I+/--L-mannopyranosyl-(1a2)-O-[O-6-deoxy-I+/--L-mannopyranosyl-(1a4)-6-deoxy-I+/--L-mannopyranosyl-(1a4)]-O-I(2)-D-glucopyranosyl-(1a4)-
137682-21-4
6-[2-(5-Amino-2-hydroxyphenyl)diazenyl]-3-[2-[4-[[4-[2-[7-[2-(5-amino-2-hydroxyphenyl)diazenyl]-1-hydroxy-3-sulfo-2-naphthalenyl]diazenyl]phenyl]amino]-3-sulfophenyl]diazenyl]-4-hydroxy-2-naphthalenesulfonic acid
1180493-25-7
O-(N-Acetyl-I+/--neuraminosyl)-(2a6)-O-I(2)-D-galactopyranosyl-(1a4)-O-2-(acetylamino)-2-deoxy-I(2)-D-glucopyranosyl-(1a6)-O-[O-I(2)-D-galactopyranosyl-(1a3)-I(2)-D-galactopyranosyl-(1a3)]-O-I(2)-D-galactopyranosyl-(1a4)-D-glucose
1620062-43-2
D-myo-Inositol, 6-O-[2-(acetylamino)-2-deoxy-I(2)-D-glucopyranosyl]-2-deoxy-, 1-[(2S,3R,3aS,4S,4a(2)S,5a(2)R,6S,7aR)-4a(2)-(benzoyloxy)decahydro-3,3a,4-trihydroxy-5a(2)-methylspiro[benzofuran-2(3H),2a(2)-[2H]pyran]-6-carboxylate]
294864-89-4
I(2)-D-Glucopyranoside, 1-methyl-1-[[3-methyl-6-(1-methylethylidene)-2-cyclohexen-1-yl]methyl]-2-propenyl O-6-deoxy-I+/--L-mannopyranosyl-(1a6)-O-[O-6-deoxy-I+/--L-mannopyranosyl-(1a4)-6-deoxy-I+/--L-mannopyranosyl-(1a2)]-
143376-49-2
O-2-(Acetylamino)-2-deoxy-I+/--D-galactopyranosyl-(1a3)-O-[6-deoxy-I+/--L-galactopyranosyl-(1a2)]-O-I(2)-D-galactopyranosyl-(1a3)-O-2-(acetylamino)-2-deoxy-I(2)-D-glucopyranosyl-(1a3)-O-I(2)-D-galactopyranosyl-(1a4)-D-glucose
88972-42-3
Octadecanamide, N-[1-[[[O-2-(acetylamino)-2-deoxy-I(2)-D-galactopyranosyl-(1a3)-O-I+/--D-galactopyranosyl-(1a4)-O-I(2)-D-galactopyranosyl-(1a4)-I(2)-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-nonadecenyl]-, [R-[R*,S*-(E)]]-
83333-10-2
Poly(oxy-1,2-ethanediyl), I+/--[3-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]propyl]-I-[[(10R)-7-hydroxy-7-oxido-13-oxo-10-[(1-oxooctadecyl)oxy]-6,8,12-trioxa-3-aza-7-phosphatriacont-1-yl]oxy]-
807352-57-4
N-[5-[[4-Chloro-6-[[8-hydroxy-3,6-disulfo-7-[2-(1-sulfo-2-naphthalenyl)diazenyl]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulfo-4-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]phenyl]-I(2)-alanine
379734-02-8